Twenty patients had hepatic resection for metastasized colorectal carcinoma (mCRC), 10 for hepatocellular carcinoma (HCC), 12 for intrahepatic or perihilar cholangiocarcinoma carcinoma (iCCA/pCCA), 1 for neuroendocrine liver metastasis (NELM), 1 for non-neuroendocrine non-colorectal (NNECR) liver metastasis and 2 patients had benign liver lesions
Injection site reactions seem to be more commonly reported by people taking tirzepatide vs
Retatrutide is not approved by Health Canada for any use
Notably, GLP-1-producing neurons within the nucleus tractus solitarius (NTS) project axons to the VTA and other limbic structures, further embedding GLP-1 signaling within neural networks that regulate reward and motivation (Llewellyn-Smith et al., 2011
Retatrutides success comes in large part from its potency against GLP-1 and its receptors
Tirzepatide microdosing success does not predict retatrutide microdosing success because the glucagon receptor component changes the equation
